| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Endothelium, Vascular | 48 | 2018 | 4459 | 3.340 |
Why?
|
| Kruppel-Like Transcription Factors | 21 | 2018 | 504 | 3.090 |
Why?
|
| Endothelial Cells | 20 | 2016 | 3486 | 1.850 |
Why?
|
| Hemodynamics | 9 | 2016 | 4196 | 1.180 |
Why?
|
| Stress, Mechanical | 16 | 2018 | 1686 | 0.950 |
Why?
|
| Hepatic Stellate Cells | 2 | 2014 | 109 | 0.880 |
Why?
|
| Simvastatin | 6 | 2018 | 360 | 0.870 |
Why?
|
| Mechanotransduction, Cellular | 6 | 2018 | 541 | 0.830 |
Why?
|
| Biomimetic Materials | 2 | 2016 | 179 | 0.810 |
Why?
|
| Organ Preservation | 5 | 2012 | 331 | 0.760 |
Why?
|
| Nitric Oxide Synthase | 15 | 2005 | 915 | 0.750 |
Why?
|
| Atherosclerosis | 10 | 2018 | 3444 | 0.740 |
Why?
|
| Shear Strength | 6 | 2013 | 165 | 0.740 |
Why?
|
| Hydrodynamics | 2 | 2011 | 158 | 0.730 |
Why?
|
| Arteriosclerosis | 4 | 2005 | 1092 | 0.640 |
Why?
|
| Liver Cirrhosis, Experimental | 3 | 2012 | 32 | 0.630 |
Why?
|
| Perfusion | 4 | 2010 | 1360 | 0.570 |
Why?
|
| Blood Gas Analysis | 1 | 2016 | 383 | 0.520 |
Why?
|
| Biomimetics | 1 | 2016 | 172 | 0.510 |
Why?
|
| Cells, Cultured | 34 | 2016 | 19233 | 0.480 |
Why?
|
| Jugular Veins | 2 | 2006 | 204 | 0.480 |
Why?
|
| Genes, Reporter | 1 | 2018 | 1547 | 0.470 |
Why?
|
| Gene Expression | 5 | 2018 | 7798 | 0.460 |
Why?
|
| Umbilical Veins | 10 | 2011 | 433 | 0.440 |
Why?
|
| Stilbenes | 2 | 2009 | 155 | 0.410 |
Why?
|
| Glycocalyx | 1 | 2012 | 88 | 0.410 |
Why?
|
| Embryonic Development | 1 | 2016 | 711 | 0.400 |
Why?
|
| Gene Expression Regulation | 17 | 2016 | 12073 | 0.400 |
Why?
|
| Induced Pluripotent Stem Cells | 2 | 2013 | 1736 | 0.400 |
Why?
|
| Caveolins | 4 | 2003 | 104 | 0.390 |
Why?
|
| Microfluidics | 1 | 2016 | 662 | 0.380 |
Why?
|
| Nitric Oxide | 14 | 2016 | 2132 | 0.380 |
Why?
|
| Hemorheology | 5 | 2016 | 145 | 0.370 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 6 | 2012 | 3255 | 0.360 |
Why?
|
| Equipment Design | 2 | 2016 | 3582 | 0.360 |
Why?
|
| Cell Differentiation | 8 | 2014 | 11486 | 0.360 |
Why?
|
| Blood Vessels | 4 | 2010 | 1125 | 0.340 |
Why?
|
| Ribonucleosides | 1 | 2009 | 82 | 0.330 |
Why?
|
| Aminoimidazole Carboxamide | 1 | 2009 | 88 | 0.330 |
Why?
|
| Cryopreservation | 2 | 2010 | 670 | 0.330 |
Why?
|
| Cell Lineage | 2 | 2016 | 2504 | 0.320 |
Why?
|
| Organ Culture Techniques | 2 | 2010 | 813 | 0.320 |
Why?
|
| Sirtuin 1 | 1 | 2009 | 246 | 0.320 |
Why?
|
| Pulsatile Flow | 4 | 2011 | 332 | 0.300 |
Why?
|
| Muscle, Smooth, Vascular | 5 | 2015 | 1504 | 0.290 |
Why?
|
| Myocytes, Smooth Muscle | 3 | 2015 | 687 | 0.290 |
Why?
|
| Models, Cardiovascular | 2 | 2010 | 996 | 0.290 |
Why?
|
| Hypertension, Portal | 4 | 2012 | 220 | 0.280 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2009 | 610 | 0.270 |
Why?
|
| Rats, Wistar | 4 | 2014 | 1892 | 0.270 |
Why?
|
| Microvessels | 1 | 2010 | 544 | 0.260 |
Why?
|
| Liver Circulation | 2 | 2012 | 164 | 0.260 |
Why?
|
| Phenotype | 12 | 2016 | 16367 | 0.250 |
Why?
|
| Blood Circulation | 1 | 2006 | 251 | 0.250 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 4 | 2004 | 3921 | 0.250 |
Why?
|
| HSP90 Heat-Shock Proteins | 4 | 2004 | 434 | 0.250 |
Why?
|
| Hematopoiesis | 2 | 2011 | 2073 | 0.250 |
Why?
|
| Oxygen | 1 | 2016 | 4189 | 0.250 |
Why?
|
| Liver Cirrhosis | 1 | 2014 | 1862 | 0.250 |
Why?
|
| Drug Discovery | 1 | 2012 | 1058 | 0.240 |
Why?
|
| Animals | 49 | 2017 | 168768 | 0.240 |
Why?
|
| Models, Biological | 4 | 2016 | 9584 | 0.240 |
Why?
|
| beta-Cyclodextrins | 1 | 2003 | 64 | 0.230 |
Why?
|
| Nitric Oxide Synthase Type III | 9 | 2013 | 689 | 0.230 |
Why?
|
| Flow Cytometry | 5 | 2018 | 5974 | 0.230 |
Why?
|
| Embryonic Stem Cells | 3 | 2014 | 1295 | 0.230 |
Why?
|
| E-Selectin | 3 | 2008 | 579 | 0.220 |
Why?
|
| Type C Phospholipases | 1 | 2003 | 292 | 0.220 |
Why?
|
| RNA, Small Interfering | 5 | 2018 | 3505 | 0.220 |
Why?
|
| Coronary Circulation | 1 | 2008 | 1572 | 0.220 |
Why?
|
| Palmitic Acids | 3 | 1996 | 54 | 0.210 |
Why?
|
| Membrane Microdomains | 1 | 2003 | 203 | 0.210 |
Why?
|
| Organ Preservation Solutions | 3 | 2012 | 98 | 0.210 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2006 | 850 | 0.210 |
Why?
|
| Renal Circulation | 2 | 2013 | 334 | 0.200 |
Why?
|
| Up-Regulation | 4 | 2014 | 4222 | 0.200 |
Why?
|
| Hematopoietic Stem Cells | 2 | 2011 | 3390 | 0.200 |
Why?
|
| Arteries | 3 | 2002 | 1119 | 0.200 |
Why?
|
| Trans-Activators | 4 | 2005 | 2926 | 0.190 |
Why?
|
| Carotid Arteries | 2 | 2007 | 950 | 0.190 |
Why?
|
| Cell Culture Techniques | 4 | 2013 | 1678 | 0.190 |
Why?
|
| Stress, Physiological | 3 | 2015 | 1403 | 0.190 |
Why?
|
| Reperfusion Injury | 3 | 2013 | 1026 | 0.180 |
Why?
|
| Mechanoreceptors | 1 | 2001 | 186 | 0.180 |
Why?
|
| MADS Domain Proteins | 2 | 2009 | 20 | 0.180 |
Why?
|
| MAP Kinase Kinase 5 | 2 | 2009 | 10 | 0.180 |
Why?
|
| Myogenic Regulatory Factors | 2 | 2009 | 106 | 0.180 |
Why?
|
| Mitogen-Activated Protein Kinase 7 | 2 | 2009 | 66 | 0.170 |
Why?
|
| Protective Agents | 2 | 2014 | 156 | 0.170 |
Why?
|
| Blood Flow Velocity | 4 | 2015 | 1423 | 0.170 |
Why?
|
| Cell Movement | 6 | 2008 | 5218 | 0.170 |
Why?
|
| Fibroblasts | 2 | 2014 | 4162 | 0.170 |
Why?
|
| High-Throughput Screening Assays | 2 | 2018 | 944 | 0.170 |
Why?
|
| Rats | 13 | 2014 | 24252 | 0.160 |
Why?
|
| Transfection | 7 | 2014 | 5895 | 0.160 |
Why?
|
| Stem Cells | 1 | 2011 | 3567 | 0.150 |
Why?
|
| Signal Transduction | 12 | 2018 | 23404 | 0.150 |
Why?
|
| DNA, Complementary | 4 | 2009 | 2050 | 0.150 |
Why?
|
| Splanchnic Circulation | 2 | 1999 | 110 | 0.150 |
Why?
|
| Promoter Regions, Genetic | 5 | 2018 | 5867 | 0.150 |
Why?
|
| Statistics as Topic | 1 | 2004 | 2373 | 0.150 |
Why?
|
| Dinoprostone | 2 | 2015 | 601 | 0.150 |
Why?
|
| Graft Rejection | 1 | 2010 | 4397 | 0.150 |
Why?
|
| Cells, Immobilized | 1 | 2016 | 36 | 0.140 |
Why?
|
| Humans | 59 | 2018 | 744366 | 0.140 |
Why?
|
| Aorta | 5 | 2016 | 2062 | 0.140 |
Why?
|
| RNA | 1 | 2006 | 2749 | 0.140 |
Why?
|
| Kidney | 1 | 2012 | 7184 | 0.140 |
Why?
|
| RNA, Messenger | 9 | 2016 | 13035 | 0.140 |
Why?
|
| Pluripotent Stem Cells | 2 | 2015 | 795 | 0.140 |
Why?
|
| Cattle | 9 | 2005 | 3922 | 0.140 |
Why?
|
| Dimethylpolysiloxanes | 1 | 2016 | 149 | 0.130 |
Why?
|
| Phosphotyrosine | 1 | 1996 | 457 | 0.130 |
Why?
|
| Regional Blood Flow | 2 | 2013 | 1525 | 0.130 |
Why?
|
| Rheology | 1 | 2016 | 345 | 0.130 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2007 | 2938 | 0.130 |
Why?
|
| Gene Expression Profiling | 4 | 2009 | 9445 | 0.130 |
Why?
|
| Caveolin 1 | 4 | 2003 | 263 | 0.130 |
Why?
|
| Phosphorylation | 7 | 2013 | 8436 | 0.120 |
Why?
|
| Membrane Proteins | 5 | 2002 | 7882 | 0.120 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 2 | 2015 | 491 | 0.120 |
Why?
|
| Capillaries | 2 | 2016 | 773 | 0.110 |
Why?
|
| Liver | 4 | 2012 | 7475 | 0.110 |
Why?
|
| von Willebrand Factor | 2 | 2016 | 669 | 0.110 |
Why?
|
| Surface Properties | 1 | 2016 | 1184 | 0.110 |
Why?
|
| Interferon Regulatory Factor-1 | 1 | 2013 | 68 | 0.110 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 2 | 2013 | 357 | 0.110 |
Why?
|
| Cell Adhesion | 4 | 2010 | 3144 | 0.110 |
Why?
|
| Cell Line | 6 | 2013 | 16000 | 0.110 |
Why?
|
| Mosaicism | 1 | 2016 | 441 | 0.110 |
Why?
|
| Materials Testing | 1 | 2016 | 867 | 0.110 |
Why?
|
| Microcirculation | 5 | 2007 | 1287 | 0.110 |
Why?
|
| American Heart Association | 1 | 2017 | 1057 | 0.110 |
Why?
|
| Models, Animal | 3 | 2012 | 2173 | 0.110 |
Why?
|
| Endothelial Growth Factors | 4 | 1998 | 694 | 0.110 |
Why?
|
| Lovastatin | 1 | 2012 | 120 | 0.110 |
Why?
|
| Antifibrinolytic Agents | 1 | 2014 | 254 | 0.100 |
Why?
|
| Quail | 1 | 2011 | 40 | 0.100 |
Why?
|
| Mice | 18 | 2016 | 81201 | 0.100 |
Why?
|
| Syndecan-1 | 1 | 2012 | 165 | 0.100 |
Why?
|
| Lymphokines | 4 | 1998 | 949 | 0.100 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2004 | 4554 | 0.100 |
Why?
|
| Heparitin Sulfate | 1 | 2012 | 225 | 0.100 |
Why?
|
| Neovascularization, Pathologic | 2 | 2001 | 2638 | 0.100 |
Why?
|
| Interferon-beta | 1 | 2013 | 324 | 0.100 |
Why?
|
| Mice, Inbred C57BL | 7 | 2014 | 21833 | 0.100 |
Why?
|
| Vanadates | 2 | 2004 | 82 | 0.100 |
Why?
|
| Cyclic AMP | 1 | 2015 | 1472 | 0.100 |
Why?
|
| Paracrine Communication | 1 | 2012 | 278 | 0.100 |
Why?
|
| Cryoprotective Agents | 1 | 2012 | 112 | 0.100 |
Why?
|
| Carbon Tetrachloride | 1 | 2010 | 64 | 0.100 |
Why?
|
| Kidney Tubules, Proximal | 1 | 2013 | 416 | 0.100 |
Why?
|
| Nucleic Acid Hybridization | 2 | 2004 | 1375 | 0.100 |
Why?
|
| DNA Methylation | 2 | 2016 | 4285 | 0.100 |
Why?
|
| Portal Pressure | 1 | 2010 | 62 | 0.090 |
Why?
|
| Organ Transplantation | 2 | 2013 | 1140 | 0.090 |
Why?
|
| DNA Primers | 3 | 2005 | 2891 | 0.090 |
Why?
|
| Microscopy, Fluorescence | 1 | 2018 | 2700 | 0.090 |
Why?
|
| Heptanoic Acids | 1 | 2012 | 343 | 0.090 |
Why?
|
| Mice, Inbred Strains | 3 | 2009 | 1828 | 0.090 |
Why?
|
| Enzyme Activation | 5 | 2007 | 3702 | 0.090 |
Why?
|
| Coculture Techniques | 2 | 2012 | 1341 | 0.090 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2009 | 4751 | 0.090 |
Why?
|
| Chimera | 1 | 2011 | 485 | 0.090 |
Why?
|
| Random Allocation | 1 | 2014 | 2428 | 0.090 |
Why?
|
| Vascular Endothelial Growth Factors | 4 | 1998 | 772 | 0.090 |
Why?
|
| Chick Embryo | 1 | 2011 | 982 | 0.090 |
Why?
|
| Systems Biology | 1 | 2013 | 469 | 0.090 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2015 | 1375 | 0.090 |
Why?
|
| Adenylate Kinase | 1 | 2009 | 99 | 0.090 |
Why?
|
| Fibroblast Growth Factor 2 | 2 | 2004 | 599 | 0.090 |
Why?
|
| Liver Diseases | 1 | 1998 | 1253 | 0.090 |
Why?
|
| Neovascularization, Physiologic | 5 | 2004 | 1351 | 0.080 |
Why?
|
| Biological Assay | 1 | 2012 | 652 | 0.080 |
Why?
|
| Internet | 1 | 2001 | 3056 | 0.080 |
Why?
|
| Embryo, Mammalian | 1 | 2015 | 1701 | 0.080 |
Why?
|
| Cardiovascular Diseases | 2 | 2012 | 15160 | 0.080 |
Why?
|
| Delayed Graft Function | 1 | 2009 | 48 | 0.080 |
Why?
|
| Regenerative Medicine | 1 | 2012 | 307 | 0.080 |
Why?
|
| Receptors, Cell Surface | 2 | 2014 | 2865 | 0.080 |
Why?
|
| Cold Temperature | 2 | 2010 | 772 | 0.080 |
Why?
|
| Tumor Necrosis Factors | 1 | 2008 | 109 | 0.080 |
Why?
|
| Umbilical Arteries | 1 | 2008 | 75 | 0.080 |
Why?
|
| Interleukin-1 | 4 | 2005 | 1263 | 0.080 |
Why?
|
| Transcription, Genetic | 5 | 2010 | 7721 | 0.080 |
Why?
|
| Leukocyte Rolling | 1 | 2007 | 72 | 0.080 |
Why?
|
| Aortic Valve | 2 | 2010 | 1924 | 0.080 |
Why?
|
| Thrombosis | 2 | 2016 | 2968 | 0.070 |
Why?
|
| Equipment Failure Analysis | 1 | 2010 | 868 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2007 | 2504 | 0.070 |
Why?
|
| Renal Insufficiency | 1 | 2013 | 804 | 0.070 |
Why?
|
| Inflammation Mediators | 1 | 2016 | 1888 | 0.070 |
Why?
|
| Immunohistochemistry | 5 | 2016 | 11366 | 0.070 |
Why?
|
| Tenascin | 1 | 2006 | 59 | 0.070 |
Why?
|
| Transplantation Immunology | 1 | 2009 | 546 | 0.070 |
Why?
|
| Protein-Lysine 6-Oxidase | 1 | 2006 | 59 | 0.070 |
Why?
|
| Intracranial Aneurysm | 1 | 2016 | 1197 | 0.070 |
Why?
|
| Aorta, Abdominal | 1 | 2009 | 646 | 0.070 |
Why?
|
| Databases, Factual | 1 | 2001 | 7730 | 0.070 |
Why?
|
| Carotid Artery Diseases | 1 | 2012 | 879 | 0.070 |
Why?
|
| Immunoblotting | 1 | 2009 | 1683 | 0.070 |
Why?
|
| Tyrosine | 2 | 2003 | 1462 | 0.070 |
Why?
|
| Tretinoin | 1 | 2009 | 517 | 0.070 |
Why?
|
| Pyrroles | 1 | 2012 | 1146 | 0.070 |
Why?
|
| Sialoglycoproteins | 1 | 2006 | 318 | 0.070 |
Why?
|
| Kidney Transplantation | 2 | 2012 | 4251 | 0.060 |
Why?
|
| Cell Communication | 1 | 2012 | 1621 | 0.060 |
Why?
|
| Elastin | 1 | 2006 | 308 | 0.060 |
Why?
|
| Osteopontin | 1 | 2006 | 294 | 0.060 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2013 | 4424 | 0.060 |
Why?
|
| Mice, Knockout | 4 | 2016 | 14561 | 0.060 |
Why?
|
| Kinetics | 3 | 2005 | 6476 | 0.060 |
Why?
|
| Base Sequence | 4 | 2005 | 12797 | 0.060 |
Why?
|
| Cadaver | 1 | 2009 | 1337 | 0.060 |
Why?
|
| Disease Models, Animal | 2 | 2014 | 18034 | 0.060 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2007 | 379 | 0.060 |
Why?
|
| Pulmonary Circulation | 2 | 1997 | 739 | 0.060 |
Why?
|
| Aorta, Thoracic | 1 | 2010 | 1084 | 0.060 |
Why?
|
| Probability | 1 | 2009 | 2506 | 0.060 |
Why?
|
| Centrifugation, Density Gradient | 1 | 2003 | 313 | 0.060 |
Why?
|
| Gene Silencing | 1 | 2010 | 1539 | 0.060 |
Why?
|
| Caveolae | 1 | 2003 | 57 | 0.060 |
Why?
|
| Cyclodextrins | 1 | 2003 | 57 | 0.060 |
Why?
|
| Monocytes | 1 | 2013 | 2596 | 0.060 |
Why?
|
| Phospholipase C gamma | 1 | 2003 | 128 | 0.060 |
Why?
|
| Arteriovenous Shunt, Surgical | 1 | 2006 | 277 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2009 | 988 | 0.060 |
Why?
|
| Molecular Targeted Therapy | 1 | 2014 | 2725 | 0.060 |
Why?
|
| Lymphangiogenesis | 1 | 2004 | 174 | 0.060 |
Why?
|
| Ischemia | 1 | 2012 | 1907 | 0.050 |
Why?
|
| Biomedical Research | 2 | 2017 | 3309 | 0.050 |
Why?
|
| HL-60 Cells | 1 | 2003 | 365 | 0.050 |
Why?
|
| Ultrasonics | 1 | 2004 | 212 | 0.050 |
Why?
|
| Receptors, Prostaglandin E | 1 | 2002 | 56 | 0.050 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2004 | 644 | 0.050 |
Why?
|
| Chemokines | 2 | 2007 | 970 | 0.050 |
Why?
|
| Quinones | 2 | 1999 | 76 | 0.050 |
Why?
|
| Male | 15 | 2014 | 350115 | 0.050 |
Why?
|
| Research Design | 1 | 2017 | 5984 | 0.050 |
Why?
|
| Methoxamine | 2 | 1999 | 45 | 0.050 |
Why?
|
| Apoptosis | 2 | 2010 | 9724 | 0.050 |
Why?
|
| Benzoquinones | 2 | 1999 | 201 | 0.050 |
Why?
|
| Epigenesis, Genetic | 1 | 2014 | 3646 | 0.050 |
Why?
|
| Venules | 1 | 2001 | 165 | 0.050 |
Why?
|
| History, 20th Century | 1 | 2009 | 2740 | 0.050 |
Why?
|
| Tissue and Organ Procurement | 1 | 2009 | 896 | 0.050 |
Why?
|
| Inflammation | 4 | 2013 | 10637 | 0.050 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2012 | 1519 | 0.050 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2011 | 1632 | 0.050 |
Why?
|
| Analysis of Variance | 1 | 2009 | 6366 | 0.050 |
Why?
|
| Graft Occlusion, Vascular | 1 | 2004 | 549 | 0.050 |
Why?
|
| Pulmonary Valve | 1 | 2004 | 437 | 0.050 |
Why?
|
| Cross-Linking Reagents | 1 | 2003 | 694 | 0.050 |
Why?
|
| Vascular Endothelial Growth Factor A | 4 | 1998 | 3511 | 0.050 |
Why?
|
| Capillary Permeability | 1 | 2004 | 798 | 0.050 |
Why?
|
| Arterioles | 1 | 2001 | 254 | 0.050 |
Why?
|
| Binding Sites | 3 | 2014 | 6111 | 0.040 |
Why?
|
| Practice Guidelines as Topic | 1 | 2017 | 7282 | 0.040 |
Why?
|
| Lactams, Macrocyclic | 2 | 1999 | 320 | 0.040 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 2 | 2013 | 264 | 0.040 |
Why?
|
| Chromatin Immunoprecipitation | 2 | 2016 | 894 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2014 | 14723 | 0.040 |
Why?
|
| Molecular Sequence Data | 4 | 2001 | 18111 | 0.040 |
Why?
|
| Palmitic Acid | 2 | 1996 | 154 | 0.040 |
Why?
|
| Cytoskeletal Proteins | 1 | 2004 | 1364 | 0.040 |
Why?
|
| Macrophages | 3 | 2015 | 5660 | 0.040 |
Why?
|
| Receptors, Vitronectin | 1 | 1998 | 52 | 0.040 |
Why?
|
| 3T3 Cells | 2 | 1998 | 1101 | 0.040 |
Why?
|
| Thrombomodulin | 2 | 2011 | 102 | 0.040 |
Why?
|
| Muscle Relaxation | 1 | 1998 | 142 | 0.040 |
Why?
|
| Th1 Cells | 1 | 2003 | 1057 | 0.040 |
Why?
|
| Th2 Cells | 1 | 2003 | 1061 | 0.040 |
Why?
|
| Genotype | 1 | 2012 | 12952 | 0.040 |
Why?
|
| Protein Transport | 1 | 2003 | 1988 | 0.040 |
Why?
|
| Receptors, Platelet-Derived Growth Factor | 1 | 1998 | 180 | 0.040 |
Why?
|
| Melanoma, Experimental | 1 | 2001 | 561 | 0.040 |
Why?
|
| Disease Susceptibility | 1 | 2004 | 1782 | 0.040 |
Why?
|
| Precipitin Tests | 1 | 1998 | 829 | 0.040 |
Why?
|
| Collagen | 3 | 2001 | 2688 | 0.040 |
Why?
|
| Golgi Apparatus | 2 | 1996 | 410 | 0.040 |
Why?
|
| Extracellular Matrix | 2 | 2004 | 1741 | 0.040 |
Why?
|
| Coronary Vessels | 1 | 2008 | 3107 | 0.040 |
Why?
|
| Vasoconstrictor Agents | 2 | 1999 | 642 | 0.040 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2004 | 1443 | 0.040 |
Why?
|
| Veins | 1 | 2001 | 770 | 0.040 |
Why?
|
| Histamine | 1 | 1998 | 507 | 0.030 |
Why?
|
| Ligands | 1 | 2003 | 3282 | 0.030 |
Why?
|
| Protein Binding | 3 | 1997 | 9384 | 0.030 |
Why?
|
| COS Cells | 1 | 1998 | 1161 | 0.030 |
Why?
|
| Mesonephros | 1 | 2015 | 41 | 0.030 |
Why?
|
| Adaptation, Physiological | 1 | 2002 | 1312 | 0.030 |
Why?
|
| Cell Compartmentation | 1 | 1996 | 402 | 0.030 |
Why?
|
| Leukocytes | 1 | 2003 | 2045 | 0.030 |
Why?
|
| Prognosis | 1 | 2016 | 29060 | 0.030 |
Why?
|
| MicroRNAs | 1 | 2011 | 3751 | 0.030 |
Why?
|
| Amino Acid Oxidoreductases | 1 | 1995 | 151 | 0.030 |
Why?
|
| Vascular Resistance | 1 | 1997 | 936 | 0.030 |
Why?
|
| Hypoxanthine Phosphoribosyltransferase | 1 | 2014 | 68 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2016 | 23336 | 0.030 |
Why?
|
| Reference Values | 2 | 2001 | 4982 | 0.030 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 1998 | 692 | 0.030 |
Why?
|
| NIH 3T3 Cells | 1 | 2016 | 677 | 0.030 |
Why?
|
| Calcium | 3 | 2013 | 5755 | 0.030 |
Why?
|
| Liver Transplantation | 2 | 2012 | 2119 | 0.030 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2016 | 712 | 0.030 |
Why?
|
| Vasoconstriction | 1 | 1996 | 597 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 1 | 2001 | 3848 | 0.030 |
Why?
|
| Sp1 Transcription Factor | 1 | 2014 | 144 | 0.030 |
Why?
|
| DNA Modification Methylases | 1 | 2014 | 206 | 0.030 |
Why?
|
| Ephrin-B2 | 2 | 2004 | 39 | 0.030 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 2 | 2008 | 707 | 0.030 |
Why?
|
| Hydrogen Peroxide | 1 | 1996 | 730 | 0.030 |
Why?
|
| Phosphates | 1 | 1996 | 785 | 0.030 |
Why?
|
| Receptor, Interferon alpha-beta | 1 | 2013 | 106 | 0.030 |
Why?
|
| DNA, Neoplasm | 1 | 1998 | 1758 | 0.030 |
Why?
|
| Immunity, Innate | 1 | 2004 | 2962 | 0.030 |
Why?
|
| Neutrophils | 2 | 2013 | 3721 | 0.030 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2015 | 514 | 0.030 |
Why?
|
| Cell Membrane | 3 | 1997 | 3749 | 0.030 |
Why?
|
| T-Lymphocytes | 1 | 2010 | 10183 | 0.030 |
Why?
|
| Vasodilation | 2 | 2011 | 944 | 0.030 |
Why?
|
| Autocrine Communication | 1 | 2013 | 171 | 0.030 |
Why?
|
| Raffinose | 1 | 2012 | 52 | 0.030 |
Why?
|
| Intercellular Adhesion Molecule-1 | 2 | 2008 | 1159 | 0.030 |
Why?
|
| Nephritis | 1 | 2013 | 159 | 0.030 |
Why?
|
| Receptors, CXCR3 | 1 | 2013 | 237 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 3 | 1999 | 8300 | 0.030 |
Why?
|
| Cell Division | 4 | 2004 | 4569 | 0.030 |
Why?
|
| STAT1 Transcription Factor | 1 | 2013 | 320 | 0.030 |
Why?
|
| Enzyme Inhibitors | 3 | 2014 | 3799 | 0.030 |
Why?
|
| Cytokines | 1 | 2006 | 7323 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2016 | 2505 | 0.020 |
Why?
|
| Blotting, Western | 4 | 2002 | 5181 | 0.020 |
Why?
|
| Reference Standards | 1 | 2015 | 1025 | 0.020 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2000 | 2455 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2012 | 17446 | 0.020 |
Why?
|
| Genome-Wide Association Study | 1 | 2009 | 12262 | 0.020 |
Why?
|
| Urinary Tract Infections | 1 | 1997 | 788 | 0.020 |
Why?
|
| Recombinant Proteins | 2 | 1997 | 6621 | 0.020 |
Why?
|
| Allopurinol | 1 | 2012 | 191 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2014 | 3617 | 0.020 |
Why?
|
| Acyl Coenzyme A | 1 | 2010 | 55 | 0.020 |
Why?
|
| Prenylation | 1 | 2010 | 37 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2010 | 12207 | 0.020 |
Why?
|
| Procaine | 1 | 2010 | 60 | 0.020 |
Why?
|
| Estradiol | 1 | 1997 | 2020 | 0.020 |
Why?
|
| Corneal Neovascularization | 2 | 2004 | 188 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 2 | 2004 | 9274 | 0.020 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2014 | 634 | 0.020 |
Why?
|
| Endothelium-Dependent Relaxing Factors | 1 | 2009 | 19 | 0.020 |
Why?
|
| Mice, Transgenic | 2 | 2014 | 9735 | 0.020 |
Why?
|
| Potassium Chloride | 1 | 2010 | 237 | 0.020 |
Why?
|
| Computer Simulation | 2 | 2016 | 6194 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2016 | 2649 | 0.020 |
Why?
|
| 3' Untranslated Regions | 1 | 2011 | 513 | 0.020 |
Why?
|
| Glutathione | 1 | 2012 | 590 | 0.020 |
Why?
|
| Mannitol | 1 | 2010 | 181 | 0.020 |
Why?
|
| Transforming Growth Factor beta | 1 | 1997 | 2007 | 0.020 |
Why?
|
| Cell Adhesion Molecules | 2 | 2007 | 1602 | 0.020 |
Why?
|
| Neoplasms | 1 | 1998 | 21696 | 0.020 |
Why?
|
| Risk Factors | 1 | 2016 | 72296 | 0.020 |
Why?
|
| Amino Acid Sequence | 2 | 1998 | 13814 | 0.020 |
Why?
|
| Homeostasis | 2 | 2011 | 3339 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2001 | 5096 | 0.020 |
Why?
|
| Bacterial Infections | 1 | 1997 | 1401 | 0.020 |
Why?
|
| Membrane Glycoproteins | 1 | 1999 | 3771 | 0.020 |
Why?
|
| omega-N-Methylarginine | 2 | 1997 | 111 | 0.020 |
Why?
|
| Bacterial Proteins | 1 | 2001 | 3854 | 0.020 |
Why?
|
| NF-kappa B | 2 | 2008 | 2499 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 1995 | 1988 | 0.020 |
Why?
|
| Software | 1 | 2001 | 4441 | 0.020 |
Why?
|
| Pulmonary Artery | 1 | 2016 | 1912 | 0.020 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 1 | 2009 | 345 | 0.020 |
Why?
|
| Gels | 2 | 1999 | 427 | 0.020 |
Why?
|
| Adenosine | 1 | 2012 | 825 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2011 | 1656 | 0.020 |
Why?
|
| Transcription Factor AP-1 | 1 | 2008 | 317 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2004 | 19905 | 0.020 |
Why?
|
| Permeability | 1 | 2007 | 738 | 0.020 |
Why?
|
| Escherichia coli | 1 | 1997 | 4217 | 0.020 |
Why?
|
| Isoenzymes | 2 | 2002 | 1728 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 1998 | 5023 | 0.020 |
Why?
|
| Models, Immunological | 1 | 2007 | 527 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2014 | 4208 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor D | 1 | 2004 | 63 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2005 | 3773 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor C | 1 | 2004 | 126 | 0.010 |
Why?
|
| Receptors, Chemokine | 1 | 2007 | 670 | 0.010 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2005 | 281 | 0.010 |
Why?
|
| Biological Transport | 2 | 2000 | 2120 | 0.010 |
Why?
|
| Vasculitis | 1 | 2007 | 519 | 0.010 |
Why?
|
| Proteins | 1 | 1998 | 6100 | 0.010 |
Why?
|
| Thromboplastin | 1 | 2005 | 291 | 0.010 |
Why?
|
| Receptors, Prostaglandin E, EP4 Subtype | 1 | 2002 | 41 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 1996 | 1723 | 0.010 |
Why?
|
| Thrombin | 1 | 2005 | 598 | 0.010 |
Why?
|
| Glutathione Transferase | 1 | 2004 | 595 | 0.010 |
Why?
|
| Zinc Fingers | 1 | 2004 | 583 | 0.010 |
Why?
|
| Oxidation-Reduction | 1 | 2007 | 2184 | 0.010 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2002 | 329 | 0.010 |
Why?
|
| Collagen Type XVIII | 1 | 2001 | 56 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 2 | 2004 | 6171 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2004 | 10943 | 0.010 |
Why?
|
| Cricetinae | 1 | 2004 | 2475 | 0.010 |
Why?
|
| Endostatins | 1 | 2001 | 174 | 0.010 |
Why?
|
| rac GTP-Binding Proteins | 1 | 2001 | 164 | 0.010 |
Why?
|
| Cytotoxins | 1 | 2001 | 153 | 0.010 |
Why?
|
| cdc42 GTP-Binding Protein | 1 | 2001 | 193 | 0.010 |
Why?
|
| Cyclooxygenase 2 | 1 | 2002 | 612 | 0.010 |
Why?
|
| Calmodulin | 1 | 2000 | 209 | 0.010 |
Why?
|
| Chemokine CCL2 | 1 | 2002 | 619 | 0.010 |
Why?
|
| Interleukin-8 | 1 | 2002 | 690 | 0.010 |
Why?
|
| Transplantation, Autologous | 1 | 2004 | 2124 | 0.010 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2001 | 293 | 0.010 |
Why?
|
| Dimerization | 1 | 2001 | 895 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 2010 | 5524 | 0.010 |
Why?
|
| Blood Coagulation | 1 | 2005 | 1127 | 0.010 |
Why?
|
| Angiopoietin-1 | 1 | 1999 | 114 | 0.010 |
Why?
|
| Rats, Zucker | 1 | 1998 | 128 | 0.010 |
Why?
|
| Vitronectin | 1 | 1998 | 44 | 0.010 |
Why?
|
| Female | 5 | 2010 | 380193 | 0.010 |
Why?
|
| Muscle, Smooth | 1 | 2002 | 934 | 0.010 |
Why?
|
| Integrin alphaV | 1 | 1998 | 55 | 0.010 |
Why?
|
| Polyunsaturated Alkamides | 1 | 1997 | 29 | 0.010 |
Why?
|
| Glucose | 1 | 2010 | 4398 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2002 | 1730 | 0.010 |
Why?
|
| Canavanine | 1 | 1997 | 14 | 0.010 |
Why?
|
| Trifluoperazine | 1 | 1997 | 40 | 0.010 |
Why?
|
| Estrogen Antagonists | 1 | 1997 | 152 | 0.010 |
Why?
|
| Acetylcholine | 1 | 1999 | 621 | 0.010 |
Why?
|
| Nitroarginine | 1 | 1997 | 66 | 0.010 |
Why?
|
| Morphogenesis | 1 | 2001 | 751 | 0.010 |
Why?
|
| Ornithine | 1 | 1997 | 78 | 0.010 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 1998 | 187 | 0.010 |
Why?
|
| Insulin | 1 | 2012 | 6582 | 0.010 |
Why?
|
| Thiourea | 1 | 1997 | 63 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-sis | 1 | 1998 | 251 | 0.010 |
Why?
|
| Receptors, Leptin | 1 | 1998 | 361 | 0.010 |
Why?
|
| Subcellular Fractions | 1 | 1997 | 547 | 0.010 |
Why?
|
| Citrulline | 1 | 1997 | 105 | 0.010 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 1997 | 254 | 0.010 |
Why?
|
| Growth Substances | 1 | 1999 | 784 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 2001 | 13104 | 0.010 |
Why?
|
| Laminin | 1 | 1998 | 419 | 0.010 |
Why?
|
| Guanidines | 1 | 1997 | 193 | 0.010 |
Why?
|
| Myristic Acid | 1 | 1995 | 47 | 0.010 |
Why?
|
| Myristic Acids | 1 | 1995 | 48 | 0.010 |
Why?
|
| Cornea | 1 | 2004 | 1524 | 0.010 |
Why?
|
| Transplantation, Homologous | 1 | 2004 | 4777 | 0.010 |
Why?
|
| Ionomycin | 1 | 1995 | 109 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2001 | 1284 | 0.010 |
Why?
|
| Membranes | 1 | 1995 | 173 | 0.010 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 1998 | 625 | 0.010 |
Why?
|
| Bradykinin | 1 | 1995 | 214 | 0.010 |
Why?
|
| Epididymis | 1 | 1997 | 227 | 0.010 |
Why?
|
| Cell Fractionation | 1 | 1995 | 252 | 0.010 |
Why?
|
| Bacterial Toxins | 1 | 2001 | 931 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 1999 | 2327 | 0.010 |
Why?
|
| Endothelium | 1 | 1997 | 778 | 0.010 |
Why?
|
| Vasodilator Agents | 1 | 1999 | 976 | 0.010 |
Why?
|
| Lipopolysaccharides | 1 | 2002 | 2216 | 0.010 |
Why?
|
| STAT3 Transcription Factor | 1 | 1998 | 874 | 0.010 |
Why?
|
| Drug Interactions | 1 | 1999 | 1460 | 0.010 |
Why?
|
| Arginine | 1 | 1997 | 944 | 0.010 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2002 | 1790 | 0.010 |
Why?
|
| Oligopeptides | 1 | 1998 | 1189 | 0.010 |
Why?
|
| Cytosol | 1 | 1995 | 901 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 1995 | 1799 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 1995 | 2646 | 0.010 |
Why?
|
| Adipocytes | 1 | 1998 | 1185 | 0.010 |
Why?
|
| Point Mutation | 1 | 1996 | 1624 | 0.010 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2001 | 2038 | 0.010 |
Why?
|
| Cysteine | 1 | 1995 | 873 | 0.010 |
Why?
|
| Leptin | 1 | 1998 | 1600 | 0.010 |
Why?
|
| Lipid Metabolism | 1 | 1998 | 1889 | 0.010 |
Why?
|
| Structure-Activity Relationship | 1 | 1995 | 3130 | 0.010 |
Why?
|
| Time Factors | 2 | 2004 | 40075 | 0.010 |
Why?
|
| Receptors, Estrogen | 1 | 1997 | 2190 | 0.010 |
Why?
|
| United States | 1 | 2017 | 69872 | 0.010 |
Why?
|
| Cell Survival | 1 | 1999 | 5882 | 0.010 |
Why?
|
| Pregnancy | 1 | 2009 | 29144 | 0.000 |
Why?
|
| Antigens, CD | 1 | 1998 | 4026 | 0.000 |
Why?
|
| Sulfonamides | 1 | 1997 | 1940 | 0.000 |
Why?
|
| Energy Metabolism | 1 | 1998 | 2897 | 0.000 |
Why?
|
| Adipose Tissue | 1 | 1997 | 3280 | 0.000 |
Why?
|
| DNA-Binding Proteins | 1 | 1998 | 9647 | 0.000 |
Why?
|
| Anti-Bacterial Agents | 1 | 1997 | 7182 | 0.000 |
Why?
|
| Middle Aged | 2 | 2004 | 213390 | 0.000 |
Why?
|
| Adult | 2 | 2004 | 214052 | 0.000 |
Why?
|
| Child | 1 | 2004 | 77709 | 0.000 |
Why?
|
| Adolescent | 1 | 2004 | 85779 | 0.000 |
Why?
|
| Aged | 1 | 1997 | 163288 | 0.000 |
Why?
|